Asset comparator
Compare stocks, ETFs, indices, commodities, cryptocurrencies and bonds over the same period. Indicators that are not meaningful for a given asset type are flagged.
- Zurich Insurance Group AG
- Novartis
Performance comparée (base 100)
Chaque actif vaut 100 au 13 octobre 2025 ; une valeur de 120 signifie +20 % depuis cette date (dernière date commune : 9 octobre 2026).
Indicateurs
« Sans objet » signale un indicateur qui n'a pas de sens pour ce type d'actif : il ne faut pas le comparer.
| Indicateur | Zurich Insurance Group AGStock | NovartisStock |
|---|---|---|
| Performance et risque | ||
| Performance over the periodChange in price between the first and last common dates. | +1.3% | +14.0% |
| Annualized performanceAverage annual return that would produce the same total performance. | +1.3% | +14.1% |
| Annualized volatilityTypical range of price movements: the higher it is, the more the price fluctuates. | 17.8% | 23.2% |
| Maximum DrawdownLargest decline from peak to subsequent trough over the period. | −12.5% | −15.0% |
| Sharpe RatioReturn achieved above the risk-free rate (5.24%), per unit of volatility. The higher it is, the better risk was rewarded over the period. | -0.13 | 0.52 |
| 1-day 95% Value at RiskOne-day loss that was exceeded in only 5% of cases (historical VaR). | −1.8% | −2.2% |
| Fondamentaux | ||
| Market capitalizationTotal market value of all shares (or circulating tokens for a crypto). | 86.04B CHF | 226.38B CHF |
| P/E (trailing 12 months)Share price divided by earnings per share: number of years of earnings paid. | 14.7 | 22.7 |
| Price-to-SalesMarket capitalization divided by annual revenue. | 1.1 | 4.0 |
| Net marginShare of revenue retained as profit. | 9.4% | 22.5% |
| Return on equityReturn on equity (ROE). | 25.7% | 30.3% |
| Revenue growthOver one year, latest published quarter compared with the same quarter of the previous year. | +11.3% | +0.8% |
| Dividend yieldAnnual dividend relative to the share price. | 5.24% | 3.14% |
| Debt / equityFinancial debt relative to shareholders' equity. | 46% | 117% |
Corrélations sur la période
De −1 à 1 : proche de 1, les deux actifs montent et baissent ensemble ; proche de 0, ils évoluent indépendamment.
- Zurich Insurance Group AG / Novartis0,29
Analyse comparative
Analyse générée par IAL'IA compare les actifs sélectionnés à partir des seuls chiffres ci-dessus, en signalant ce qui n'est pas comparable. Le texte n'est généré qu'à votre demande.
Informations fournies à titre pédagogique. Elles ne constituent ni un conseil en investissement ni une recommandation personnalisée. Les performances passées ne préjugent pas des performances futures.